{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:00:59Z","timestamp":1780426859287,"version":"3.54.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>\n                    Cervical cancer radiotherapy often faces challenges in managing gastrointestinal toxicities, particularly due to the dose received by the small intestine. This study investigates the impact of optimization structure margins (1.2\u20132.4\u2009cm) on reducing small intestine dose and improving plan quality in patients with mean small intestine doses (D\n                    <jats:sub>mean_INT<\/jats:sub>\n                    ) exceeding 25 Gy. A total of 27 cervical cancer patients treated with volumetric modulated arc therapy were retrospectively analyzed. Iterative constraint adjustments were applied to optimization structures at varying distances from the planning target volume (PTV). Five optimization margins (0.6, 1.2, 1.8, 2.4, and 3.0\u2009cm) were created by volumetrically excluding small intestine regions proximal to PTV, with iterative dose constraints. Each plan was named RrIi, where r represents the cutting distance of the optimization structure and i represents the iteration number (ranging from 4\u20138). Results demonstrated that all optimized plans achieved significant reductions in D\n                    <jats:sub>mean_INT<\/jats:sub>\n                    compared to the original plans (ORI group), with reductions ranging from 1.21 to 1.83 Gy (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). The R_1.2I_5.5 protocol achieved the most favorable balance, reducing D\n                    <jats:sub>mean_INT<\/jats:sub>\n                    by 1.23 Gy, corresponding to a 15% to 22% relative risk reduction for Grade\u2005\u2265\u20052 enteritis. Smaller margins (1.2\u2009cm) effectively reduced intermediate-high-dose regions (e.g., V\n                    <jats:sub>40Gy<\/jats:sub>\n                    ), while larger margins (2.4\u2009cm) better controlled low-dose regions (e.g., V\n                    <jats:sub>15Gy<\/jats:sub>\n                    ), supporting tailored clinical decision-making based on patient characteristics. In conclusion, optimization structure margins of 1.2 to 2.4\u2009cm provide a clinically meaningful framework for reducing small intestine dose while preserving PTV coverage, advancing cervical cancer radiotherapy planning.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044715","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:00:54Z","timestamp":1759248054000},"page":"e44715","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dosimetric study on the effect of minimum distance between optimization structures and planning target volume on small intestine dose in cervical cancer VMAT plans"],"prefix":"10.1097","volume":"104","author":[{"given":"Rui","family":"Ban","sequence":"first","affiliation":[{"name":"Department of Gynecology, Department of Gynecological Oncology, Tianjin Institute of Gynaecology Obsterics, Tianjin Central Hospital of Gynaecology Obsterics, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Department of Gynecological Oncology, Tianjin Institute of Gynaecology Obsterics, Tianjin Central Hospital of Gynaecology Obsterics, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4896-284X","authenticated-orcid":false,"given":"Jinlong","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Department of Gynecological Oncology, Tianjin Institute of Gynaecology Obsterics, Tianjin Central Hospital of Gynaecology Obsterics, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri.","volume":"143","author":"Bhatla","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.radonc.2015.02.010","article-title":"What is the normal tissues morbidity following helical intensity modulated radiation treatment for cervical cancer?","volume":"115","author":"Mouttet-Audouard","year":"2015","journal-title":"Radiother Oncol"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ijrobp.2012.10.004","article-title":"Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.","volume":"85","author":"Poorvu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijrobp.2009.04.048","article-title":"Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model.","volume":"77","author":"Robertson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.radonc.2017.07.005","article-title":"Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: first quantification of bowel dose-volume effects.","volume":"124","author":"Sini","year":"2017","journal-title":"Radiother Oncol"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ijrobp.2007.03.060","article-title":"The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry.","volume":"69","author":"Huang","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203.","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3 Suppl","key":"R8-20260602","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel.","volume":"76","author":"Kavanagh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.2147\/OTT.S178336","article-title":"Dosimetric comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy in patients with cervical cancer: a meta-analysis.","volume":"11","author":"Bai","year":"2018","journal-title":"Onco Targets Ther"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.radonc.2008.06.013","article-title":"A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy.","volume":"89","author":"Cozzi","year":"2008","journal-title":"Radiother Oncol"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/acm2.12003","article-title":"Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.","volume":"18","author":"Deng","year":"2017","journal-title":"J Appl Clin Med Phys"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2009.10.075","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer.","volume":"79","author":"Lim","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7785\/tcrt.2012.500283","article-title":"Correlation of three different approaches of small bowel delineation and acute lower gastrointestinal toxicity in adjuvant pelvic intensity-modulated radiation therapy for endometrial cancer.","volume":"11","author":"Chi","year":"2012","journal-title":"Technol Cancer Res Treat"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tipsro.2019.09.001","article-title":"Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer \u2013 a multicentre dose planning study.","volume":"11","author":"Appelt","year":"2019","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1002\/mp.16468","article-title":"Delineation of clinical target volume and organs at risk in cervical cancer radiotherapy by deep learning networks.","volume":"50","author":"Tian","year":"2023","journal-title":"Med Phys"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"841980","DOI":"10.3389\/fonc.2022.841980","article-title":"Clinical outcomes of MRI-guided adaptive brachytherapy for each fraction in locally advanced cervical cancer: a single institution experience.","volume":"12","author":"Chi","year":"2022","journal-title":"Front Oncol"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1016\/j.ijrobp.2013.06.1107","article-title":"An assessment of organ-at-risk dose and interfraction variability using 4 different applicators for intracavitary gynecologic HDR brachytherapy.","volume":"87","author":"Banerjee","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"175015","DOI":"10.1088\/1361-6560\/acecd2","article-title":"Deep learning-based dose map prediction for high-dose-rate brachytherapy.","volume":"68","author":"Li","year":"2023","journal-title":"Phys Med Biol"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.radonc.2011.10.022","article-title":"Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise.","volume":"102","author":"Gulliford","year":"2012","journal-title":"Radiother Oncol"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas.","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2020.09.022","article-title":"Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer.","volume":"154","author":"Gort","year":"2021","journal-title":"Radiother Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:01:15Z","timestamp":1780423275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":21,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044715","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2025-05-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}